American Renal Associates Holdings, Inc
ARA
ARA was delisted on the 25th of January, 2021.
82 hedge funds and large institutions have $547M invested in American Renal Associates Holdings, Inc in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 32 reducing their positions, and 14 closing their positions.
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
9% more capital invested
Capital invested by funds: $501M → $547M (+$45.1M)
3% more funds holding
Funds holding: 80 → 82 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
20% less call options, than puts
Call options by funds: $477K | Put options by funds: $595K
28% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$5.52M |
| 2 |
JP Morgan Chase
New York
|
+$3.78M |
| 3 |
Renaissance Technologies
New York
|
+$3.24M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.48M |
| 5 |
ACM
Argent Capital Management
St Louis,
Missouri
|
+$2.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TimesSquare Capital Management
New York
|
-$4.99M |
| 2 |
AAM
AMI Asset Management
Los Angeles,
California
|
-$1.59M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.55M |
| 4 |
Millennium Management
New York
|
-$1.48M |
| 5 |
PP
PDT Partners
New York
|
-$1.32M |
ARA Hedge Fund Activity: Q1 2018 in Review
82 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q1 2018, worth a combined $547M — up 9% from $501M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ARA positions and 14 closed out — a net gain of 2 holders — while 23 added to existing stakes and 32 trimmed.
The largest buyer was OppenheimerFunds, opening a new position worth an estimated $5.52M. The largest seller was TimesSquare Capital Management, cutting an estimated $4.99M.
- 82 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q1 2018, up from 80 in Q4 2017.
- Funds reported $547M of American Renal Associates Holdings, Inc stock for Q1 2018, up 9% quarter-over-quarter.
- 16 funds opened new American Renal Associates Holdings, Inc positions in Q1 2018 and 14 closed out, a net change of +2 holders.
- The largest American Renal Associates Holdings, Inc buyer in Q1 2018 was OppenheimerFunds, an estimated $5.52M added.
- The largest American Renal Associates Holdings, Inc seller in Q1 2018 was TimesSquare Capital Management, an estimated $4.99M sold.
Based on aggregated 13F filings for Q1 2018.